<DOC>
	<DOC>NCT00981682</DOC>
	<brief_summary>The hypothesis of this study is that SER120 is safe and well tolerated for use in nocturic patients.</brief_summary>
	<brief_title>Long Term Safety Assessment of SER120 in Patients With Nocturia</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Patients completed SPCSER120DB1200901 and SPCSER120DB2200902 studies Willing to provide consent for the study Incontinence Diabetes Insipidus, Diabetes Mellitus CHF Renal Insufficiency Significant medical history which make participation unacceptable</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>decrease in the number of nocturic episodes for patients with nocturia</keyword>
</DOC>